Shandong Weigao Group repurchases shares, boosting treasury holdings

On December 4, 2025, Shandong Weigao Group Medical Polymer Company Limited repurchased 74,000 ordinary H shares on the Exchange. The shares were bought at prices ranging from HK$5.47 to HK$5.59, for a total of HK$410,120. These repurchased shares will be held as treasury shares, increasing the total treasury share count from 27,535,200 to 27,609,200.

Following the repurchase, the number of issued shares (excluding treasury shares) decreased by 74,000 to 4,494,723,124, representing a 0.0016% change. The total number of issued shares, including treasury shares, remains at 4,522,332,324.

The company's mandate, authorized on May 27, 2025, allows for the repurchase of up to 451,560,392 shares. To date, 20,960,800 shares have been repurchased on the Exchange, representing 4.6419% of the issued shares as of the resolution date. A moratorium period for new share issues or sales of treasury shares extends until January 3, 2026.